Research map: Integrating Network Pharmacology and Experimental Validation Reveals EGFR/PI3K/Akt Axis Mediates Ibrutinib-Induced Cardiotoxicity

Back to the article

Papers in this map

  1. Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia · John C. Byrd · 2013 · 2284 citations · Cited by this paper
  2. Piperine Targets the FANCL/UBE2T Complex to Inhibit the FA Pathway and Sensitize Bladder Cancer to Cisplatin · 2025 · Related
  3. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL · Michael J. Hallek · 2018 · 1755 citations · Cited by this paper
  4. The U-Shaped Relationship Between Serum Bicarbonate Levels and 28-Day Mortality in Patients With Sepsis: A Retrospective Cohort Study of MIMIC-IV Database · 2025 · Related
  5. Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia · Tait D. Shanafelt · 2019 · 754 citations · Cited by this paper
  6. miRNA-Targeted Herbal Compounds Against Gastric Precancerous Evolution in Chronic Atrophic Gastritis · 2026 · Related
  7. Cardiovascular Toxicities Associated With Ibrutinib · Joe‐Elie Salem · 2019 · 266 citations · Cited by this paper
  8. Phenotypic Age Acceleration and Risk of All-Cause and Cardiovascular Mortality in US Adults With Asthma: A Retrospective Cohort Study · 2025 · Related
  9. Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL · Jennifer R. Brown · 2017 · 243 citations · Cited by this paper
  10. The Quercetin Paradox, Evaluation of its Therapeutic Efficacy as a Nutraceutical in Clinical Trials: Evidence and Speculation · 2026 · Related
  11. The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis · Darryl P. Leong · 2016 · 234 citations · Cited by this paper
  12. Dosimetric Effect of Thymus on Radiation-Induced Lymphopenia in Breast Cancer Patients Who Received Adjuvant Radiotherapy · 2025 · Related
  13. Ventricular arrhythmias and sudden death in patients taking ibrutinib · Benjamin L. Lampson · 2017 · 214 citations · Cited by this paper
  14. Association of Type 2 Diabetes Mellitus and Risk of Colorectal Cancers in Pyogenic Liver Abscess · 2026 · Related
  15. Interplay between PI3K/AKT pathway and heart disorders · Soudeh Ghafouri‐Fard · 2022 · 192 citations · Cited by this paper
  16. Exploring the Therapeutic Potential of Virtual Screened Novel HER2 Inhibitors via QSAR, Molecular Docking and Dynamics Simulations · 2025 · Related
  17. Thalidomide: A Banned Drug Resurged into Future Anticancer Drug · Imran Ali · 2012 · 103 citations · Cited by this paper
  18. Glass-Based Bone-Equivalent Retrospective Dosimeters: A Comprehensive Review of Thermoluminescence and Structural Evolution · 2026 · Related
  19. Ibrutinib combinations in CLL therapy: scientific rationale and clinical results · Natalia Timofeeva · 2021 · 72 citations · Cited by this paper
  20. Heart Failure With Targeted Cancer Therapies · Virginia Shalkey Hahn · 2021 · 72 citations · Cited by this paper
  21. Analyses of anticancer drugs by capillary electrophoresis: a review · Imran Ali · 2013 · 60 citations · Cited by this paper
  22. Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes · Sanam Shafaattalab · 2019 · 54 citations · Cited by this paper
  23. Celastrol pretreatment attenuates rat myocardial ischemia/ reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K/Akt pathway · Suiyang Tong · 2018 · 53 citations · Cited by this paper
  24. Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical · Rong Dong · 2022 · 39 citations · Cited by this paper
  25. Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity · Benjamin Harding Buck · 2023 · 33 citations · Cited by this paper
  26. A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Targeting Inflammation · Siming Li · 2018 · 19 citations · Cited by this paper
  27. Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in isolated mouse ventricular myocytes · Daniel Tarnowski · 2023 · 12 citations · Cited by this paper
  28. Mitigating Ibrutinib‐Induced Ventricular Arrhythmia and Cardiac Dysfunction With Metformin · Pengsha Li · 2024 · 8 citations · Cited by this paper
  29. Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database · Zeng‐Xiang Zhao · 2024 · 7 citations · Cited by this paper
  30. In silico analysis of atrial fibrillation and hypertension mechanism of action secondary to ibrutinib/acalabrutinib in chronic lymphocytic leukemia · Raúl Córdoba · 2025 · 7 citations · Cited by this paper
  31. Advancing Drug Repurposing for Rheumatoid Arthritis: Integrating Protein–Protein Interaction, Molecular Docking, and Dynamics Simulations for Targeted Therapeutic Approaches · Akey Krishna Swaroop · 2025 · 6 citations · Cited by this paper
  32. Developmental and metabolic toxicity of diphenyl phosphate: insights from an integrative mechanistic framework in zebrafish embryos · Jiahang Li · 2026 · 4 citations · Cited by this paper
  33. Atrial fibrillation associated with tyrosine kinase inhibitors: A case–control study of real-world pharmacovigilance data · Jun Wang · 2026 · 1 citation · Cited by this paper
  34. Untitled · Cited by this paper
  35. Untitled · Cited by this paper
  36. Untitled · Cited by this paper

Source: OpenAlex (CC0)